Sign In
Pricing

300343 (Harmonized System 2017 for 6-digit)

2022
World Trade $762kRnk 5348 / 5380
2022
Top Exporter | Top Importer $387k | $378kUnited States | Haiti
2022
Product Complexity -0.11Rnk 3116 / 5381
2021 - 2022
Export Growth (CAGR) 36.6%Rnk 412 / 5380
2022
Share of World Trade <0.01%Rnk 5348 / 5380

About

Overview This page contains the latest trade data of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale. In 2022, Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale were the world's 5348th most traded product, with a total trade of $762k. Between 2021 and 2022 the exports of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale grew by 36.6%, from $558k to $762k. Trade in Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale represent 0.0000032% of total world trade.

Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale are a part of Medicaments; (not goods of heading no. 3002, 3005 or 3006) of two....

Exports In 2022 the top exporters of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale  were United States ($387k), Tunisia ($176k), India ($83.7k), Guatemala ($64.7k), and Portugal ($29.8k).

Imports In 2022 the top importers of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale were Haiti ($378k), Germany ($113k), Nigeria ($83.7k), Nicaragua ($64.7k), and Mauritania ($64.7k).

Ranking Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale ranks 3116th in the Product Complexity Index (PCI).

Latest Trends

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

Explore Latest Trends

* Trade values are converted to USD using each month's exchange rate. For December 2023 data, the exchange rate from December 30, 2023 is used.

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2022)United States$387k
Top Destination (2022)Haiti$378k

In 2022 Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale were the world's 5348th most traded product (out of 5,380).

In 2022, the top exporters of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale were United States ($387k), Tunisia ($176k), India ($83.7k), Guatemala ($64.7k), and Portugal ($29.8k).

In 2022, the top importers of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale were Haiti ($378k), Germany ($113k), Nigeria ($83.7k), Nicaragua ($64.7k), and Mauritania ($64.7k).

Explore Visualizations

Exporters of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale (2022)
[Click to Select a Country]

Importers of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale (2022)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (2021 -  2022)United States$386k
Top Destination Growth (2021 -  2022)Haiti$378k

Between 2021 and 2022, the exports of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale grew the fastest in United States ($386k), Tunisia ($176k), India ($83.6k), Portugal ($29.8k), and Guatemala ($22.3k).

Between 2021 and 2022, the fastest growing importers of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale were Haiti ($378k), Nigeria ($83.7k), Mauritania ($64.7k), Spain ($29.8k), and Nicaragua ($22.3k).

Explore Visualizations

Exporters of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale (2021 - 2022)

Importers of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale (2021 - 2022)

Market Concentration

Value

This chart shows the evolution of the market concentration of exports of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale.

In 2022, market concentration measured using Shannon Entropy, was 2.04. This means that most of the exports of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale are explained by 4 countries.

Explore Visualizations

Value of Exports in Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale

Net Trade

TOP NET EXPORTER (2022)United States$384k
TOP NET IMPORTER (2022)Germany$110k

This map shows which countries export or import more of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale. Each country is colored based on the difference in exports and imports of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale during 2022.

In 2022, the countries that had a largest trade value in exports than in imports of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale were United States ($384k), Tunisia ($176k), India ($83.7k), Guatemala ($64.7k), and Portugal ($29.8k).

In 2022, the countries that had a largest trade value in imports than in exports of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale were Germany ($110k) and Spain ($29.7k).

Net Trade (2022)

Country Comparison

Flow
Measure
Ranking

This visualization shows the countries that have an important ratio of their trade related to Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale.
It is possible to select the main countries that export or import Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale in the world, or by continent, as well as select the measure of interest.

Top 10 Exporters Countries of Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, not packaged for retail sale by percentage of total exports

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2022)

Keep Exploring

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with
About the OECPrivacy PolicyTerms